TherapeuticsMD | TXMD - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.84B 205M 2026-09
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
CSL USD 1.23B 498M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Novo Nordisk DKK 2.54B 10.68B 2026-06
Pfizer USD 3.28B 132M 2026-09
TherapeuticsMD USD 1.23M 90K 2024-06